Ledger.Open graph →
SEC Form D · filed June 4, 2024

Inhibikase Therapeutics, Inc

Offering
$8.0M
Sold
—
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Atlanta, GA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Paul H. Grint · Atlanta, GADirectorMilton H. Werner · Atlanta, GAExec · DirectorGisele H. Dion · Atlanta, GADirectorRoy H. Freeman · Atlanta, GADirectorGarth H. Lees-Rolfe · Atlanta, GAExecDennis H. Berman · Atlanta, GADirectorPaul H. Grint · Atlanta, GADirectorMilton H. Werner · Atlanta, GAExec · DirectorGisele H. Dion · Atlanta, GADirectorRoy H. Freeman · Atlanta, GADirectorGarth H. Lees-Rolfe · Atlanta, GAExecDennis H. Berman · Atlanta, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗